Jefferies Group LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 100 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$1,185,000
+178.2%
130,920
+336.4%
0.01%
+400.0%
Q2 2018$426,000
+44.4%
30,000
+66.6%
0.00%
+100.0%
Q4 2017$295,000
+586.0%
18,005
+363.2%
0.00%
Q2 2015$43,000
-95.5%
3,887
-93.8%
0.00%
-100.0%
Q4 2014$961,000
+150.3%
63,167
+77.4%
0.01%
+100.0%
Q3 2014$384,000
-13.3%
35,615
-15.7%
0.00%
-25.0%
Q3 2013$443,000
+29.9%
42,224
-3.2%
0.00%0.0%
Q2 2013$341,00043,6000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2013
NameSharesValueWeighting ↓
Alexandria Capital, LLC 968,505$12,135,0001.23%
Golden State Equity Partners 126,608$1,586,0000.90%
McGuire Investment Group, LLC 272,801$3,418,0000.72%
Lombard Odier Asset Management (Switzerland) SA 848,429$10,631,0000.70%
Rhenman & Partners Asset Management AB 765,000$9,585,0000.67%
EMC Capital Management 72,061$903,0000.64%
WASATCH ADVISORS LP 10,328,423$129,415,0000.58%
Ceeto Capital Group, LLC 74,000$927,0000.45%
Fort Sheridan Advisors LLC 75,945$952,0000.38%
Vanguard Capital Wealth Advisors 34,580$388,679,0000.33%
View complete list of SANGAMO THERAPEUTICS INC shareholders